In Depth 15 Jan 2025
CRISPR: The gene editing tool changing the world (2025 update)
CRISPR-Cas9 has changed the world with the promise of making gene editing much easier and faster than before. But what is its real potential?
CRISPR
- Latest Posts
In Depth 18 Dec 2024
AI + CRISPR: The explosive fusion that will redefine biotechnology
With AI taking more and more space in biotech, CRISPR stands out as one of the most promising avenues for AI integration.
More News! 10 Dec 2024
Biotech in 2024: A retrospective
2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism?
News and Trends 31 Oct 2024
Halloween biotech stories: Unveiling scientists’ worst fears
What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.
News and Trends 21 Oct 2024
Turning back time with cellular reprogramming: Shift raises $16 million in seed funding
As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.
Podcast 9 Aug 2024
Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA
This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi.
ADVERTISEMENT
ADVERTISEMENT
In Depth 8 Jul 2024
Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR
Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique.
In Depth 27 Jun 2024
CRISPR-Cas13: how does the technology compare to its famous Cas9 cousin?
Discover more about CRISPR-Cas13, including how it differs from CRISPR-Cas9 and what the technology can be used for.
In Depth 6 Jun 2024
CRISPR: A promising path to treating blindness
Rigorous research, which has been going on for more than a decade now, suggests that CRISPR could treat genetic diseases including blindness.
In Depth 23 May 2024
Is prime editing ready for prime time?
Prime editing, a more advanced version of CRISPR/Cas9 technology, has been greenlit by the FDA to begin the first-ever clinical trial for this technology.
Podcast 5 Apr 2024
Colossal Biosciences’ 2028 goal: Bringing back the woolly mammoth
Discover the pioneering work of Colossal Biosciences, a biotech firm leading the charge in de-extinction and endangered species preservation.
In Depth 4 Apr 2024
Seven diseases CRISPR technology could cure
Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool.
ADVERTISEMENT
